BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

Documents & Downloads

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -1.13% -6.90% -17.54% 8.57% -3.39% -0.78% 0.46% -3.13% 14.45% 04/07/2010
BIB NAV -1.08% -7.11% -17.59% 8.57% -3.48% -0.81% 0.42% -3.14% 14.44% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.14%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/02/2025
  • NAV
    $47.24
  • NAV Change
    $+1.68 up caret
  • Market Price
    $47.26
  • Market Price Change
    $+1.69 up caret
  • Trading Volume (M)
    8,682
  • 30-Day Median Bid Ask Spread
    0.30%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.14%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/02/2025
  • NAV
    $47.24
  • NAV Change
    $+1.68 up caret
  • Market Price
    $47.26
  • Market Price Change
    $+1.69 up caret
  • Trading Volume (M)
    8,682
  • 30-Day Median Bid Ask Spread
    0.30%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 12/31/2024

Holdings

as of 4/02/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
6.87% VRTX VERTEX PHARMACEUTICALS INC -- $3,602,483.99 7,451 2931034
6.77% AMGN AMGEN INC -- $3,547,342.80 11,604 2023607
6.67% GILD GILEAD SCIENCES INC -- $3,499,024.08 31,272 2369174
5.72% REGN REGENERON PHARMACEUTICALS -- $2,998,500.80 4,793 2730190
3.58% AZN ASTRAZENECA PLC-SPONS ADR -- $1,874,758.98 25,959 2989044
2.94% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,539,875.93 5,771 B00FWN1
1.63% BIIB BIOGEN INC -- $856,863.00 6,525 2455965
1.59% ARGX ARGENX SE - ADR -- $832,825.74 1,427 BDVLM39
1.32% SNY SANOFI-ADR -- $691,099.50 12,810 2964557
1.28% SMMT SUMMIT THERAPEUTICS INC -- $672,827.10 32,885 BMTVQS7
1.19% UTHR UNITED THERAPEUTICS CORP -- $625,144.52 2,002 2430412
1.15% RPRX ROYALTY PHARMA PLC- CL A -- $604,235.76 19,317 BMVP7Y0
1.13% INSM INSMED INC -- $592,587.36 8,069 2614487
1.11% BMRN BIOMARIN PHARMACEUTICAL INC -- $580,993.28 8,504 2437071
1.10% ILMN ILLUMINA INC -- $578,236.56 7,062 2613990
1.03% INCY INCYTE CORP -- $537,720.91 8,627 2471950
0.98% ONC BEIGENE LTD-ADR -- $512,739.48 1,866 BYYWPW6
0.92% NBIX NEUROCRINE BIOSCIENCES INC -- $481,437.95 4,445 2623911
0.91% MRNA MODERNA INC -- $476,756.28 17,199 BGSXTS3
0.88% EXEL EXELIXIS INC -- $462,148.08 12,477 2576941
0.88% VTRS VIATRIS INC -- $460,824.58 53,213 BMWS3X9
0.81% MEDP MEDPACE HOLDINGS INC -- $422,650.34 1,358 BDCBC61
0.79% BNTX BIONTECH SE-ADR -- $413,874.20 4,435 BK6H543
0.78% ASND ASCENDIS PHARMA A/S - ADR -- $409,574.34 2,692 BV9G6B8
0.71% TEM TEMPUS AI INC -- $371,780.28 7,452 BSLSJJ0
0.66% HALO HALOZYME THERAPEUTICS INC -- $345,979.80 5,490 2975098
0.65% JAZZ JAZZ PHARMACEUTICALS PLC -- $342,399.52 2,708 B4Q5ZN4
0.63% MDGL MADRIGAL PHARMACEUTICALS INC -- $329,246.40 984 BD59BS7
0.61% ROIV ROIVANT SCIENCES LTD -- $320,634.72 31,809 BMW4NZ9
0.56% BBIO BRIDGEBIO PHARMA INC -- $293,542.98 8,479 BK1KWG8
0.55% RVMD REVOLUTION MEDICINES INC -- $286,764.80 8,288 BL71K91
0.52% SRPT SAREPTA THERAPEUTICS INC -- $270,182.75 4,325 B8DPDT7
0.49% BPMC BLUEPRINT MEDICINES CORP -- $256,438.49 2,849 BWY52P3
0.46% GH GUARDANT HEALTH INC -- $239,281.98 5,502 BFXC911
0.46% AXSM AXSOME THERAPEUTICS INC -- $238,596.50 2,174 BYZR4X4
0.45% ALKS ALKERMES PLC -- $236,679.85 7,249 B3P6D26
0.44% KRYS KRYSTAL BIOTECH INC -- $232,404.00 1,284 BD6JX35
0.41% ADMA ADMA BIOLOGICS INC -- $213,183.74 10,538 B9NSBM2
0.41% CYTK CYTOKINETICS INC -- $212,479.75 5,279 BBBSBJ5
0.40% VRNA VERONA PHARMA PLC - ADR -- $211,798.77 3,513 BYWPZK5
0.40% NUVL NUVALENT INC-A -- $207,857.00 2,950 BMVBZD3
0.39% IONS IONIS PHARMACEUTICALS INC -- $203,439.06 7,086 BDJ0LS6
0.37% PCVX VAXCYTE INC -- $193,380.60 5,740 BKPVGH6
0.32% PTCT PTC THERAPEUTICS INC -- $170,068.92 3,516 B17VCN9
0.31% ACLX ARCELLX INC -- $164,713.50 2,450 BPCJ1Q2
0.30% RNA AVIDITY BIOSCIENCES INC -- $159,537.43 5,359 BMWHPY1
0.30% SWTX SPRINGWORKS THERAPEUTICS INC -- $155,376.80 3,340 BGMGM89
0.28% AKRO AKERO THERAPEUTICS INC -- $148,922.50 3,550 BK7Y2V9
0.28% RYTM RHYTHM PHARMACEUTICALS INC -- $146,423.28 2,818 BF2YWG4
0.28% RARE ULTRAGENYX PHARMACEUTICAL IN -- $145,865.88 4,124 BJ62Z18
0.26% SRRK SCHOLAR ROCK HOLDING CORP -- $137,351.34 4,221 BFZQ0L8
0.25% MRUS MERUS NV -- $132,470.80 3,080 BZBY005
0.25% PTGX PROTAGONIST THERAPEUTICS INC -- $131,875.20 2,736 BDCBCD8
0.25% CRSP CRISPR THERAPEUTICS AG -- $130,708.37 3,823 BDHF4K6
0.25% CRNX CRINETICS PHARMACEUTICALS IN -- $130,205.72 4,148 BDD19F8
0.25% APLS APELLIS PHARMACEUTICALS INC -- $128,685.00 5,595 BYTQ6X1
0.24% IMVT IMMUNOVANT INC -- $124,348.66 7,573 BJRFSB7
0.24% ACAD ACADIA PHARMACEUTICALS INC -- $123,569.70 7,435 2713317
0.24% ALVO ALVOTECH SA -- $123,504.41 13,439 BPNTJ34
0.23% LEGN LEGEND BIOTECH CORP-ADR -- $121,026.84 3,641 BMX9K07
0.22% AMRX AMNEAL PHARMACEUTICALS INC -- $112,893.06 13,818 BFNF1D6
0.21% FOLD AMICUS THERAPEUTICS INC -- $109,431.04 13,696 B19FQ48
0.20% XENE XENON PHARMACEUTICALS INC -- $107,341.52 3,412 BRJ3GY4
0.20% VCYT VERACYTE INC -- $104,671.62 3,474 BFTWZY0
0.19% TWST TWIST BIOSCIENCE CORP -- $101,600.39 2,659 BGKG6G7
0.19% ZLAB ZAI LAB LTD-ADR -- $101,566.84 2,788 BD9GVY0
0.19% IBRX IMMUNITYBIO INC -- $99,277.50 32,550 BNSP0B8
0.19% VCEL VERICEL CORP -- $98,678.37 2,227 BSBMN89
0.19% MIRM MIRUM PHARMACEUTICALS INC -- $98,325.00 2,185 BJDX8Y8
0.18% LGND LIGAND PHARMACEUTICALS -- $93,399.07 859 2501578
0.18% RXRX RECURSION PHARMACEUTICALS-A -- $93,167.48 17,612 BM9FJ13
0.17% -- NEWAMSTERDAM PHARMA CO NV -- $89,156.16 4,896 BP8JSP4
0.17% DNLI DENALI THERAPEUTICS INC -- $88,952.76 6,474 BD2B4V0
0.17% TARS TARSUS PHARMACEUTICALS INC -- $88,099.39 1,711 BMH5RL1
0.17% NVCR NOVOCURE LTD -- $87,888.06 4,899 BYSS4X4
0.17% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $87,797.40 5,289 BKX9VD3
0.16% HRMY HARMONY BIOSCIENCES HOLDINGS -- $83,146.68 2,556 BKSGZN7
0.16% SUPN SUPERNUS PHARMACEUTICALS INC -- $81,656.16 2,488 B72ZBG4
0.15% KYMR KYMERA THERAPEUTICS INC -- $76,312.20 2,895 BMPRZV5
0.14% APGE APOGEE THERAPEUTICS INC -- $75,924.81 2,007 BM9HHL5
0.14% CGON CG ONCOLOGY INC -- $75,460.32 3,393 BRBCSP4
0.14% IRON DISC MEDICINE INC -- $74,784.73 1,541 BMGJZJ8
0.14% JANX JANUX THERAPEUTICS INC -- $74,438.75 2,635 BMFX8Y7
0.14% AGIO AGIOS PHARMACEUTICALS INC -- $72,635.76 2,554 BCBVTX1
0.14% ARWR ARROWHEAD PHARMACEUTICALS IN -- $71,330.49 5,621 BYQBFJ8
0.14% DVAX DYNAVAX TECHNOLOGIES CORP -- $71,183.97 5,531 BRJZSK0
0.14% TVTX TRAVERE THERAPEUTICS INC -- $70,970.64 3,956 BLFGJD5
0.13% BCRX BIOCRYST PHARMACEUTICALS INC -- $69,217.88 9,316 2100362
0.13% BEAM BEAM THERAPEUTICS INC -- $68,930.40 3,730 BK6L288
0.13% MNKD MANNKIND CORP -- $67,935.66 13,533 BF081J4
0.13% ANIP ANI PHARMACEUTICALS INC -- $67,279.20 970 BCDWBX6
0.13% VERA VERA THERAPEUTICS INC -- $67,042.78 2,842 BL55460
0.12% EWTX EDGEWISE THERAPEUTICS INC -- $65,525.44 4,222 BKY5JZ8
0.12% IDYA IDEAYA BIOSCIENCES INC -- $63,797.70 3,902 BK0VHF6
0.11% AMPH AMPHASTAR PHARMACEUTICALS IN -- $59,575.40 2,143 BNFWZS4
0.11% SPRY ARS PHARMACEUTICALS INC -- $56,532.60 4,332 BMCR7V2
0.11% CNTA CENTESSA PHARMACEUTICALS-ADR -- $55,745.30 4,069 BLB0YQ9
0.10% INDV INDIVIOR PLC -- $52,683.68 5,534 BP0BQQ5
0.10% ADPT ADAPTIVE BIOTECHNOLOGIES -- $52,237.26 6,579 BJ5FZ74
0.10% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $51,973.38 1,766 BLCD809
0.10% ARDX ARDELYX INC -- $51,854.88 10,626 BN89V40
0.10% IOVA IOVANCE BIOTHERAPEUTICS INC -- $51,740.64 14,616 BF0DMK7
0.10% WVE WAVE LIFE SCIENCES LTD -- $51,468.43 6,799 BYZG9R0
0.10% OCUL OCULAR THERAPEUTIX INC -- $51,438.72 7,008 BNZB1X8
0.10% PCRX PACIRA BIOSCIENCES INC -- $51,348.07 2,063 B3X26D8
0.10% INVA INNOVIVA INC -- $50,487.58 2,794 BDDXF67
0.10% AUPH AURINIA PHARMACEUTICALS INC -- $50,147.37 6,123 BFWLC09
0.10% DYN DYNE THERAPEUTICS INC -- $49,976.13 5,043 BN15WD1
0.09% SNDX SYNDAX PHARMACEUTICALS INC -- $49,363.82 3,806 BN7Q7R7
0.09% ETNB 89BIO INC -- $46,792.52 6,508 BK1K484
0.09% GERN GERON CORP -- $45,144.87 28,393 2370381
0.09% GPCR STRUCTURE THERAPEUTICS INC -- $45,019.20 2,656 BQS9486
0.08% ELVN ENLIVEN THERAPEUTICS INC -- $43,255.08 2,178 BMFD115
0.08% NVAX NOVAVAX INC -- $42,876.60 7,170 BJDQXG4
0.08% TXG 10X GENOMICS INC-CLASS A -- $42,701.25 4,825 BKS3RS7
0.08% COLL COLLEGIUM PHARMACEUTICAL INC -- $42,090.00 1,403 BX7RSN3
0.08% SYRE SPYRE THERAPEUTICS INC -- $41,606.14 2,686 BQBBDY8
0.08% HROW HARROW INC -- $41,367.40 1,588 BHNDW86
0.08% KNSA KINIKSA PHARMACEUTICALS INTE -- $40,925.05 1,873 BRXB0C0
0.08% GRFS GRIFOLS SA-ADR -- $40,730.62 5,438 B8K7T65
0.08% VIR VIR BIOTECHNOLOGY INC -- $39,618.72 6,114 BK4PZ38
0.07% GRAL GRAIL INC -- $39,157.72 1,498 BSLSSX7
0.07% NRIX NURIX THERAPEUTICS INC -- $38,498.54 3,383 BMVLGP2
0.07% ZYME ZYMEWORKS INC -- $36,594.40 3,070 BPCQZY9
0.07% DAWN DAY ONE BIOPHARMACEUTICALS I -- $36,008.46 4,518 BLB0YH0
0.07% GMAB GENMAB A/S -SP ADR -- $35,193.40 1,870 BBC9WC7
0.07% EOLS EVOLUS INC -- $34,497.06 2,823 BDRJH21
0.07% XERS XERIS BIOPHARMA HOLDINGS INC -- $34,226.90 6,646 BLR7H87
0.06% NTLA INTELLIA THERAPEUTICS INC -- $33,689.50 4,615 BYZM6C2
0.06% PRAX PRAXIS PRECISION MEDICINES I -- $33,361.89 899 BQ721R4
0.06% AVXL ANAVEX LIFE SCIENCES CORP -- $32,459.52 3,792 BYTYP72
0.06% AVDL AVADEL PHARMACEUTICALS -- $32,048.16 4,296 BDGMC59
0.06% LENZ LENZ THERAPEUTICS INC -- $31,275.26 1,226 BQV0J03
0.06% MLYS MINERALYS THERAPEUTICS INC -- $31,094.00 2,221 BP9N0G0
0.06% XNCR XENCOR INC -- $30,844.62 3,141 BGCYWN8
0.06% FTRE FORTREA HOLDINGS INC -- $30,032.49 3,999 BRXYZ57
0.06% RCKT ROCKET PHARMACEUTICALS INC -- $29,943.90 4,753 BDFKQ07
0.06% ABUS ARBUTUS BIOPHARMA CORP -- $29,648.97 8,447 BZ0QMB7
0.06% REPL REPLIMUNE GROUP INC -- $29,592.46 3,433 BDDVW37
0.06% ABCL ABCELLERA BIOLOGICS INC -- $29,490.48 13,284 BL53SR3
0.06% PRTA PROTHENA CORP PLC -- $29,123.86 2,399 B91XRN2
0.06% COGT COGENT BIOSCIENCES INC -- $29,029.00 5,075 BLR6XK8
0.05% CVAC CUREVAC NV -- $28,600.00 10,000 BN4RD42
0.05% AVBP ARRIVENT BIOPHARMA INC -- $27,036.00 1,502 BMGTLY5
0.05% ANAB ANAPTYSBIO INC -- $25,931.99 1,367 BDRW1L7
0.05% CSTL CASTLE BIOSCIENCES INC -- $25,661.49 1,271 BKLCWZ3
0.05% QURE UNIQURE NV -- $25,594.20 2,410 BJFSR88
0.05% TRVI TREVI THERAPEUTICS INC -- $25,013.24 3,983 BJH9ZN0
0.05% KALV KALVISTA PHARMACEUTICALS INC -- $24,431.27 2,203 BD06CS0
0.04% KURA KURA ONCOLOGY INC -- $23,472.00 3,600 BYZD465
0.04% SVRA SAVARA INC -- $23,029.51 7,651 BYXGN81
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $22,158.24 3,484 BFYQFJ2
0.04% ARVN ARVINAS INC -- $22,006.70 3,065 BDZ30Q0
0.04% HCM HUTCHMED CHINA-ADR -- $21,973.80 1,382 BYXV9H7
0.04% SAGE SAGE THERAPEUTICS INC -- $21,297.57 2,741 BP4GNK9
0.04% URGN UROGEN PHARMA LTD -- $21,078.40 1,882 BZ7PJQ1
0.04% ALMS ALUMIS INC -- $20,713.20 2,105 BPLQG36
0.04% OMER OMEROS CORP -- $20,689.83 2,583 B4NB858
0.04% CGEM CULLINAN THERAPEUTICS INC -- $20,402.38 2,609 BM90J52
0.04% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $19,841.40 906 BL95N25
0.04% TBPH THERAVANCE BIOPHARMA INC -- $19,749.92 2,192 BMNDK09
0.04% MNMD MIND MEDICINE MINDMED INC -- $19,515.93 3,269 BPQYY97
0.04% TYRA TYRA BIOSCIENCES INC -- $19,514.40 2,256 BMVNDH9
0.04% PGEN PRECIGEN INC -- $19,322.88 13,056 BKM5C84
0.04% RLAY RELAY THERAPEUTICS INC -- $18,816.93 7,557 BN2R582
0.03% ORIC ORIC PHARMACEUTICALS INC -- $18,299.48 3,166 BKVDFF7
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $18,230.80 2,380 BLFBZ32
0.03% KROS KEROS THERAPEUTICS INC -- $18,152.32 1,808 BM7V485
0.03% MESO MESOBLAST LTD- SPON ADR -- $17,919.12 1,516 BQS7491
0.03% SIGA SIGA TECHNOLOGIES INC -- $17,506.50 3,183 2107437
0.03% CRMD CORMEDIX INC -- $17,041.50 2,705 BJ0LT31
0.03% PHAT PHATHOM PHARMACEUTICALS INC -- $16,739.01 3,049 BJLKVS6
0.03% ALT ALTIMMUNE INC -- $16,409.74 3,433 BFY7DC4
0.03% EYPT EYEPOINT PHARMACEUTICALS INC -- $16,340.91 3,043 BMGS7L1
0.03% RAPP RAPPORT THERAPEUTICS INC -- $16,244.76 1,631 BR3T9B6
0.03% SANA SANA BIOTECHNOLOGY INC -- $16,223.39 9,953 BMFJJ97
0.03% GLPG GALAPAGOS NV-SPON ADR -- $15,949.50 651 B292NQ7
0.03% ERAS ERASCA INC -- $15,879.78 12,603 BNLYBF3
0.03% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $15,810.20 1,964 BKDQKM6
0.03% ORKA ORUKA THERAPEUTICS INC -- $15,721.98 1,669 BKVF0J2
0.03% STOK STOKE THERAPEUTICS INC -- $15,582.60 2,361 BJQ05Z6
0.03% RGNX REGENXBIO INC -- $15,573.45 2,209 BZ0G875
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $15,504.16 12,208 B4N8MH9
0.03% VERV VERVE THERAPEUTICS INC -- $15,479.69 3,959 BNKGXX2
0.03% TRML TOURMALINE BIO INC -- $15,316.20 1,143 BQ80NC6
0.03% TRDA ENTRADA THERAPEUTICS INC -- $14,748.80 1,676 BP81RK8
0.03% RNAC CARTESIAN THERAPEUTICS INC -- $14,672.35 1,133 BQB9HM8
0.03% AMLX AMYLYX PHARMACEUTICALS INC -- $14,439.60 3,820 BPCK358
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $14,313.06 786 BQD3J33
0.03% AUTL AUTOLUS THERAPEUTICS PLC -- $14,026.38 8,934 BFMLGR4
0.03% PSNL PERSONALIS INC -- $14,008.60 3,935 BJQ0608
0.03% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $13,973.83 6,323 BMCWKZ2
0.03% ATXS ASTRIA THERAPEUTICS INC -- $13,888.32 2,516 BMYRFN8
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $13,459.68 9,347 BFZNYB7
0.03% AURA AURA BIOSCIENCES INC -- $13,222.44 2,226 BP81R42
0.02% TKNO ALPHA TEKNOVA INC -- $12,978.42 2,377 BP7L561
0.02% MXCT MAXCYTE INC -- $12,977.52 4,702 BKMQF66
0.02% ABSI ABSCI CORP -- $12,697.60 5,120 BN94K69
0.02% SLDB SOLID BIOSCIENCES INC -- $12,553.38 3,402 BQHN6C7
0.02% OABI OMNIAB INC -- $12,435.48 5,395 BN13S71
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $12,354.56 4,064 BYVQJ96
0.02% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $12,321.60 1,208 BKC9SX3
0.02% SLRN ACELYRIN INC -- $12,299.86 4,489 BQPF874
0.02% ESPR ESPERION THERAPEUTICS INC -- $12,209.76 8,784 BBNBTD2
0.02% GLUE MONTE ROSA THERAPEUTICS INC -- $12,078.99 2,739 BP7KZP7
0.02% TSHA TAYSHA GENE THERAPIES INC -- $12,063.48 9,139 BNC1BX1
0.02% TECX TECTONIC THERAPEUTIC INC -- $11,771.62 658 BPBPCG8
0.02% VNDA VANDA PHARMACEUTICALS INC -- $11,726.00 2,600 B12W3P6
0.02% TSVT 2SEVENTY BIO INC -- $11,408.00 2,300 BMTXV88
0.02% OLMA OLEMA PHARMACEUTICALS INC -- $11,018.97 3,309 BMZ4LN0
0.02% AVIR ATEA PHARMACEUTICALS INC -- $10,843.20 3,765 BLN9Z50
0.02% PRME PRIME MEDICINE INC -- $10,466.13 5,847 BPBJFM7
0.02% IRWD IRONWOOD PHARMACEUTICALS INC -- $10,272.96 7,134 B3MZ6K5
0.02% YMAB Y-MABS THERAPEUTICS INC -- $9,585.60 1,997 BG31GH0
0.02% DSGN DESIGN THERAPEUTICS INC -- $9,565.96 2,524 BMFK3H6
0.02% TERN TERNS PHARMACEUTICALS INC -- $9,429.63 3,787 BMDJ0C9
0.02% ITOS ITEOS THERAPEUTICS INC -- $9,399.33 1,629 BMWXFT4
0.02% ANNX ANNEXON INC -- $9,313.92 4,752 BMVV9R5
0.02% CRVS CORVUS PHARMACEUTICALS INC -- $9,196.65 2,865 BYP80F1
0.02% CDXS CODEXIS INC -- $9,195.57 3,693 B5LL2C2
0.02% INBX INHIBRX BIOSCIENCES INC -- $9,094.50 645 BNSP8K3
0.02% CRGX CARGO THERAPEUTICS INC -- $8,675.73 2,051 BQHN2F2
0.02% CMPS COMPASS PATHWAYS PLC -- $8,553.12 2,768 BMC3HS7
0.02% FHTX FOGHORN THERAPEUTICS INC -- $8,478.18 2,479 BMF7DT9
0.02% HUMA HUMACYTE INC -- $8,373.10 5,735 BMYTJP4
0.02% TVGN TEVOGEN BIO HOLDINGS INC -- $8,350.28 7,804 BPG5P75
0.02% VYGR VOYAGER THERAPEUTICS INC -- $8,303.35 2,435 BY7RB53
0.02% ACIU AC IMMUNE SA -- $8,287.04 4,408 BZC0D70
0.02% LXRX LEXICON PHARMACEUTICALS INC -- $8,106.95 16,114 BWFZX59
0.01% AMRN AMARIN CORP PLC -ADR -- $7,712.06 17,852 2301938
0.01% THRD THIRD HARMONIC BIO INC -- $7,131.95 2,009 BNNPQY8
0.01% NGNE NEUROGENE INC -- $6,924.52 662 BS2F741
0.01% NMRA NEUMORA THERAPEUTICS INC -- $6,772.76 7,202 BN4JN37
0.01% FDMT 4D MOLECULAR THERAPEUTICS IN -- $6,769.92 2,064 BKLXFX5
0.01% LYEL LYELL IMMUNOPHARMA INC -- $6,609.68 13,024 BN6MB18
0.01% TNGX TANGO THERAPEUTICS INC -- $6,602.03 4,819 BP2P6L0
0.01% LRMR LARIMAR THERAPEUTICS INC -- $6,256.80 2,844 BMXNGZ6
0.01% SLN SILENCE THERAPEUTICS PLC-ADR -- $6,057.44 2,096 BL5B6Z1
0.01% NKTX NKARTA INC -- $6,006.95 3,145 BK80YJ8
0.01% SCPH SCPHARMACEUTICALS INC -- $5,575.00 2,230 BYX2Z16
0.01% ALEC ALECTOR INC -- $5,212.06 4,417 BJ4LDC4
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $5,040.30 951 B9L5200
0.01% CCCC C4 THERAPEUTICS INC -- $4,809.28 3,164 BKX9NQ0
0.01% EDIT EDITAS MEDICINE INC -- $4,342.40 3,680 BZ8FPH3
0.01% LXEO LEXEO THERAPEUTICS INC -- $4,340.93 1,474 BQ6C357
0.01% KYTX KYVERNA THERAPEUTICS INC -- $4,138.75 1,925 BSMLR16
0.01% FATE FATE THERAPEUTICS INC -- $3,909.29 5,077 BCZS820
0.01% PLRX PLIANT THERAPEUTICS INC -- $3,825.33 2,713 BMDWW66
0.01% CLYM CLIMB BIO INC -- $3,626.37 2,997 BMW5LX6
0.01% BMEA BIOMEA FUSION INC -- $3,490.56 1,616 BNKF6N0
0.01% MGNX MACROGENICS INC -- $3,413.56 2,798 BFDV8K0
0.01% ARTV ARTIVA BIOTHERAPEUTICS INC -- $3,097.38 1,083 BMF1LJ7
0.01% TCRX TSCAN THERAPEUTICS INC -- $2,780.03 2,189 BNLYBJ7
0.01% PYXS PYXIS ONCOLOGY INC -- $2,704.02 2,651 BLBR8D5
0.01% INZY INOZYME PHARMA INC -- $2,653.21 2,864 BMVLGY1
-- ACRV ACRIVON THERAPEUTICS INC -- $2,415.12 1,388 BP2TPK4
-- OKUR ONKURE THERAPEUTICS INC-A -- $2,329.32 564 BT7KGT6
-- STRO SUTRO BIOPHARMA INC -- $2,317.35 3,676 BF12XC2
-- APLT APPLIED THERAPEUTICS INC -- $2,287.47 5,187 BJL38Z1
-- PEPG PEPGEN INC -- $2,128.68 1,458 BMTX3D7
-- MRSN MERSANA THERAPEUTICS INC -- $1,871.83 5,507 BF3NP05
-- IGMS IGM BIOSCIENCES INC -- $1,868.37 1,519 BKS3SM8
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- QTTB Q32 BIO INC -- $806.36 543 BS2FKQ4
41.59% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 21,808,694 -- 5,181 --
25.34% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 13,284,740 -- 3,156 --
24.53% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 12,863,804 -- 3,056 --
11.69% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 6,128,828 -- 1,456 --
10.61% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 5,560,565 -- 1,321 --
7.63% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 3,998,892 -- 950 --
-- -- UNITED STATES OF AMERICA BILL ZERO CPN 27/MAY/2025 USD 100 -- $7,452,437.78 7,500,000 --
-- -- TREASURY BILL -- $3,977,900.20 4,000,000 BSZBFQ4
-- -- TREASURY BILL -- $2,973,896.10 3,000,000 BSNQ2D7
-- -- UNITED STATES OF AMERICA BILL ZERO CPN 26/JUN/2025 USD 100 -- $742,659.19 750,000 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $-3,705,289.93 -3,705,290 --

Index

as of 12/31/2024

  • Total Number of Companies265
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$5.58 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.